A case of hidradenitis suppurativa successfully treated with apremilast in a patient with psoriasis and SAMPUS
- 22 April 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (3), e13448
- https://doi.org/10.1111/dth.13448
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- Psoriasis and hidradenitis suppurativa: A large-scale population-based studyJournal of the American Academy of Dermatology, 2023
- Epidemiology, clinical presentation, and pathogenesisJournal of the American Academy of Dermatology, 2020
- Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trialJournal of the American Academy of Dermatology, 2019
- Systematic review and meta-analysis of the association between psoriasis and metabolic syndromeJournal of the American Academy of Dermatology, 2017
- Recurrence of Melanoma after Starting Apremilast for PsoriasisCase Reports in Dermatology, 2017
- SAMPUS, MELTUMP and THIMUMP – Diagnostic Categories Characterized by Uncertain Biological BehaviorKlinicka onkologie, 2017
- Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)Journal of the American Academy of Dermatology, 2017